// App-Quantinova.ai

OP0100 : MOLECULAR PROFILING OF PERIPHERAL IMMUNE CELL SUBSETS IN PATIENTS WITH RHEUMATOID ARTHRITIS

Researchers

Presenter

  • P. C. Taylor

Principal Investigators

  • J. Liu

  • L. Zhuo

  • Y. Tian

  • T. Snyder

  • C. Kim

  • P. Kheradpour

  • K. Drake

  • S. Kim

  • R. E. Hawtin

Medical Centers

  • University of Oxford Botnar Research Centre, Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom

  • Gilead Sciences Inc, Foster City, United States of America, Foster City, CA

  • Kezar Life Sciences, South San Francisco, CA, United States of America

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Peripheral blood mononuclear cell

Drug/Treatment

  • Methotrexate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02889796

  • NCT02886728

Sponsors

  • Gilead Sciences

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved